Editorial: which biologic is next for ulcerative colitis patients who fail a subcutaneous anti-TNF?

Ahmad Albshesh; Shomron Ben-Horin

doi:10.1111/apt.15712

Editorial: which biologic is next for ulcerative colitis patients who fail a subcutaneous anti-TNF?

Ahmad Albshesh^*
, Shomron Ben-Horin

^*Corresponding author for this work

Internal Medicine

Sheba Medical Center at Tel Hashomer

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	1198-1199
Number of pages	2
Journal	Alimentary Pharmacology and Therapeutics
Volume	51
Issue number	11
DOIs	https://doi.org/10.1111/apt.15712
State	Published - 1 Jun 2020

Access to Document

10.1111/apt.15712

Cite this

@article{9659fd7c84e6403fbaaa30884064e26c,

title = "Editorial: which biologic is next for ulcerative colitis patients who fail a subcutaneous anti-TNF?",

author = "Ahmad Albshesh and Shomron Ben-Horin",

year = "2020",

month = jun,

day = "1",

doi = "10.1111/apt.15712",

language = "אנגלית",

volume = "51",

pages = "1198--1199",

journal = "Alimentary Pharmacology and Therapeutics",

issn = "0269-2813",

publisher = "John Wiley and Sons Inc.",

number = "11",

}

TY - JOUR

T1 - Editorial

T2 - which biologic is next for ulcerative colitis patients who fail a subcutaneous anti-TNF?

AU - Albshesh, Ahmad

AU - Ben-Horin, Shomron

PY - 2020/6/1

Y1 - 2020/6/1

UR - https://www.scopus.com/pages/publications/85084787984

U2 - 10.1111/apt.15712

DO - 10.1111/apt.15712

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.editorial???

C2 - 32424929

AN - SCOPUS:85084787984

SN - 0269-2813

VL - 51

SP - 1198

EP - 1199

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

IS - 11

ER -

Editorial: which biologic is next for ulcerative colitis patients who fail a subcutaneous anti-TNF?

Access to Document

Other files and links

Cite this